China Cracks Down on Foreign Pharmaceutical Companies for Price Fixing
A storm is brewing in China, as the country has begun a series of crackdowns on various industries for offenses ranging from bribery to price fixing.
India Relaxes Foreign Investment Cap to Woo Growth
While the rupee has been falling and growth has slowed, contributing to a record deficit, India has embarked on a series of measures designed to reverse the negative trend.
Is France’s Economy a Surprise Threat to Eurozone?
The “bad boys” of the southern Eurozone, Greece, Spain and Italy, have gotten most of the attention when it comes to a possible Eurozone breakup, but the real threat may lie in an unexpected direction.
8 Most & Least Bullish Big Cities
Investors around the country see the economic picture looking brighter. But how much brighter depends, in part, on where they live.
While Actavis (ACT) narrowed its 2013 guidance expectations in the wake of an unexpected Concerta approval, the company is still poised to post close to 30% EPS growth and potentially double-digit annual EPS growth through 2016.
T. Rowe’s In-House Doctor Gives Healthcare Stock Picks for 2013
T. Rowe Price’s doctor is in–and diagnosing where the best stock picks can be found in the healthcare sector as reforms take hold next year.
Top 20 New Mega Donors
Wealth-X tags the new crop of elite philanthropists following in the footsteps of Carnegie and Rockefeller.
EEI: ‘Congress & President Must Act Now To Extend Current Dividend Tax Rates’
Today our nation is facing a series of tax hikes and mandatory spending cuts that threaten to send the economy over a ‘fiscal cliff’ at the end of the year.
Solid growth and promising research and development pipelines bode well for companies that sell pharmaceutical and related health-care products.
What Obama Health Law Means Now That It’s Called a Tax
Considering the Patient Protection and Affordable Care Act’s broad reach, one simple thing is true of the PPACA’s potential tax and investment consequences: it’s complicated.